ESCRS - 40 million Ugandans share 41 eye specialists

40 million Ugandans share 41 eye specialists

Eye diseases are among the top ten causes of morbidity in Uganda

40 million Ugandans share 41 eye specialists
Colin Kerr
Colin Kerr
Published: Wednesday, August 16, 2017

 

 Uganda is a signatory to the World Health Organization strategy for elimination of avoidable blindness by the year 2020. Figures from the Health Management Information System indicate that eye diseases are among the top ten causes of morbidity in Uganda. It is estimated that between 300,000 and 350,000 people in Uganda are blind and more than 1.2 million have visual impairment. However, Uganda is faced with an acute shortage of ophthalmologists. About 170,000 Ugandans are blind due to cataracts and that number increases annually by 20 per cent, representing 34,000 new cases every year, according to The Observer http://observer.ug/lifestyle/54205-all-40-million-ugandans-share-41-eye-specialists.html
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...